Employees showing rising interest in personalized medicine, targeted health education
Both plan sponsors and plan members are expressing an interest in personalized medicine that offers a targeted approach to prescribing based on patients’ genetic makeup, according to the 2017 Sanofi Canada health-care survey. These tests are becoming more accessible and more affordable, said Paula Allen, vice-president of research and integrative solutions at Morneau Shepell Ltd. and one of the survey’s advisory board members. “This is a good news story coming out of this year’s survey, when you think of the value in terms of improving health outcomes and maximizing the investment in drug plans.”
Read more on Benefits Canada.